Inotuzumab ozogamicin is deliverable in relapsed ALL patients with end-stage renal disease on hemodialysis. Issue 13 (10th November 2022) - Amanam, Idoroenyi; Ngo, Dat; Pullarkat, Vinod; Aldoss, Ibrahim